SCHEMBL10018865

SCHEMBL10018865

CC1(C)c2ccccc2-c2c(-c3cccc4c3sc3c(-c5cccc6c5-c5ccccc5C6(C)C)cccc34)cccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLNR O43193 1/20 0.36
NR1I2 O75469 1/20 0.36
CHRM2 P08172 1/20 0.36
ADRB1 P08588 1/20 0.36
HTR1A P08908 1/20 0.36
ADRA2A P08913 1/20 0.36
CHRM1 P11229 1/20 0.36
DRD2 P14416 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
CHRM3 P20309 1/20 0.36
DRD1 P21728 1/20 0.36
SLC6A2 P23975 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
SLC6A4 P31645 1/20 0.36
ADRA1A P35348 1/20 0.36
HRH1 P35367 1/20 0.36
OPRM1 P35372 1/20 0.36
DRD3 P35462 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29293166 0.83 PDK2 (0.37) ALOX5PDK2LIMK1
SCHEMBL10018864 0.83 PARP14 (0.37) MLNRNR1I2CHRM2ADRB1HTR1A
SCHEMBL17944886 0.82 CYP1A1 (0.35) MEN1KMT2A
SCHEMBL29293047 0.82 PDK2 (0.43) KCNH2PDK2LIMK1
SCHEMBL21688333 0.81 KDM4E (0.34) PARP14ALOX5MEN1KMT2APDK2
SCHEMBL22706583 0.81 ALOX5 (0.44) KCNH2PARP14ALOX5
SCHEMBL23376022 0.81 PARP14 (0.39) MLNRNR1I2CHRM2ADRB1HTR1A
SCHEMBL15275847 0.80 PDK2 (0.36) MLNRNR1I2CHRM2ADRB1HTR1A
SCHEMBL22084521 0.80 PARP14 (0.38) PARP14ALOX5
SCHEMBL22057482 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8743031-B2 Dibenzothiophene compound and organic light-emitting element based on the same CANON KABUSHIKI KAISHA (JP) 2014-06-03 US disclosed
US-8743031-B2 Dibenzothiophene compound and organic light-emitting element based on the same CANON KABUSHIKI KAISHA (JP) 2014-06-03 US disclosed
US-20120075171-A1 DIBENZOTHIOPHENE COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT BASED ON THE SAME CANON KABUSHIKI KAISHA (JP) 2012-03-29 US disclosed
US-20120075171-A1 DIBENZOTHIOPHENE COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT BASED ON THE SAME CANON KABUSHIKI KAISHA (JP) 2012-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120075171-A1 DIBENZOTHIOPHENE COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT BASED ON THE SAME TPT1, RFT1, ARNT MLNR 3842/4885NR1I2 27/4885CHRM2 2851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.